Bank Of America Corp Sqz Biotechnologies CO Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.27 - $0.68 $808 - $2,035	-2,993 Reduced 70.24%	1,268 $0
Q1 2023 May 12, 2023	SELL	$0.53 - $0.87 $5,303 - $8,705	-10,006 Reduced 70.13%	4,261 $2,000
Q4 2022 Feb 10, 2023	SELL	$0.67 - $2.85 $5,607 - $23,851	-8,369 Reduced 36.97%	14,267 $10,000
Q3 2022 Nov 14, 2022	BUY	$2.16 - $3.48 $69 - $111	32 Added 0.14%	22,636 $51,000
Q2 2022 Aug 12, 2022	SELL	$2.77 - $5.0 $23,184 - $41,850	-8,370 Reduced 27.02%	22,604 $71,000
Q1 2022 May 16, 2022	SELL	$4.01 - $10.42 $26,337 - $68,438	-6,568 Reduced 17.5%	30,974 $149,000
Q4 2021 Feb 08, 2022	BUY	$8.93 - $14.85 $44,908 - $74,680	5,029 Added 15.47%	37,542 $335,000
Q3 2021 Nov 15, 2021	SELL	$11.46 - $15.77 $18,920 - $26,036	-1,651 Reduced 4.83%	32,513 $469,000
Q2 2021 Sep 13, 2021	BUY	$11.32 - $14.45 $386,736 - $493,669	34,164 New	34,164 $494,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.